The price of global health : drug pricing strategies to balance patient access and the funding of innovation / by Ed Schoonveld.
By: Schoonveld, Ed [author.].
Material type:![materialTypeLabel](/opac-tmpl/lib/famfamfam/BK.png)
Item type | Current location | Collection | Call number | URL | Copy number | Status | Date due | Item holds |
---|---|---|---|---|---|---|---|---|
![]() |
IUKL Library | Subscripti | http://site.ebrary.com/lib/kliuc/Doc?id=11011396 | 1 | Available |
Includes bibliographical references and index.
The drug pricing challenge -- Payers -- Fundamentals of pricing -- Reference based pricing -- Health outcomes and health economics -- Features, benefits, value and price -- Pricing and drug development -- Payer segmentation -- Key situation factors : the podium approach -- The best price framework to pricing and market access -- Payer value story -- Developing a global pricing strategy -- Public policy and ethical considerations -- Oncology and orphan drugs -- Payer and pricing research -- Corporate market access and pricing function -- Market access and pricing negotiations -- Risk sharing and managed entry agreements -- United states -- Canada -- France -- Germany -- Italy -- Spain -- UK -- Japan -- Australia -- Brazil -- China -- India -- South korea.
Description based on print version record.
Electronic reproduction. Palo Alto, Calif. : ebrary, 2015. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.
There are no comments for this item.